Log in

Teniposide Sometimes Effective in Brain Metastases from Non-small Cell Lung Cancer

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

In a prospective study we have treated 13 patients with brain metastases from non-small cell lung cancer with intravenous teniposide, at a dose of 150 mg/m2 on days 1, 3 and 5 given every 3 weeks on an out-patient basis. Six of the 13 patients had previously been treated for brain metastases by surgery and/or radiotherapy. Seven patients experienced neurological improvement. Objective response was obtained in 3 patients (23%) (2 PR, 1 CR), and stabilization in 5 patients. Duration of response in the 3 patients with objective response was 16 weeks, 40 weeks and 80 weeks, respectively. In 2 of these patients extracranial disease responded also to teniposide therapy. Although toxicity of teniposide therapy was relatively mild, there was one patient who died as a consequence of leukopenic sepsis. The results demonstrate that teniposide has some activity in de novo as well as recurrent brain metastases from non-small cell lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. CA Cancer J Clin 40: 9–26, 1990

    PubMed  Google Scholar 

  2. Travis WD, Travis LB, Devesa SS: Lung cancer. Cancer 75(suppl): 191–202, 1995

    PubMed  Google Scholar 

  3. Posner JB: Neurologic Complications of Cancer. FA Davis Co, Philadelphia, 1995

    Google Scholar 

  4. Sørensen JB, Hansen HH, Hansen M, Dombernowsky P: Brain metastases in adenocarcinoma of the lung; frequency, risk groups and prognosis. J Clin Oncol 6: 1474–1480, 1988

    PubMed  Google Scholar 

  5. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery. Ann Neurol 33: 583–590, 1993

    PubMed  Google Scholar 

  6. Borgelt B, Gelber R, Kramer S, Bray LW, Chang CH, Davis LW, Perez CA, Henderrickson FR: The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Rad Biol Phys 6: 1–9, 1980

    Google Scholar 

  7. Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7: 529–541, 1980

    Google Scholar 

  8. Hazuka MB, Kinzie JJ: Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 15: 433–437, 1988

    PubMed  Google Scholar 

  9. Kristensen CA, Kristjansen PEG, Hansen HH: Systemic chemotherapy of brain metastases from small cell lung cancer: a review. J Clin Oncol 10: 1498–1502, 1992

    PubMed  Google Scholar 

  10. Van Zandwijk N, Giaccone G: Treatment of metastatic nonsmall cell lung cancer (NSCLC). Curr Opinion Oncol 8: 120–125, 1996

    Google Scholar 

  11. Giaccone G, Donadio M, Ferrati P, Bonardi G, Ciuffreda L, Bagatella M, Calciati A: Teniposide in the treatment of nonsmall cell lung carcinoma. Cancer Treat Rep 71: 83–85, 1987

    PubMed  Google Scholar 

  12. Van Tellingen O, Boogerd W, Nooijen WJ, Beijnen JH: The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue. Cancer Chemother Pharmacol 40: 330–334, 1997

    PubMed  Google Scholar 

  13. Kleisbauer JP, Vesco D, Orehek J, Blaive B, Clary C, Poirier R, Saretto S, Carles P, Dongay G, Guerin JC, Martinat Y: Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the group franc¸ais pneumo-cancérologie. Eur J Cancer Clin Oncol 24: 131–135, 1988

    PubMed  Google Scholar 

  14. Viens P, Lagrange J, Thyss A, Ayela P, Frenay M, Schneider M: Brain metastases of lung cancer: excessive toxicity of high dose VP16–213. Eur J Cancer Clin Oncol 24: 1905–1906, 1988

    Google Scholar 

  15. Workman P: The pharmacology of brain tumor chemotherapy. In: Bleehen NM (ed) Tumours of the Brain. Springer-Verlag Berlin, 1986, pp 183–200

    Google Scholar 

  16. Cumin I, Lacroix H, MahéM, Dutin JP, Dabouis G: Efficacité de l'association mitomycine, ifosfamide, cisplatine avec irradiation pour le traitement des métastases cérébrales des cancers bronchiques non `a petites cellules. Bull Cancer 82: 57–62, 1995

    PubMed  Google Scholar 

  17. Furuse K, Kamimori T, Kawahara M, Kodama N, Ogawara M, Atagi S, Naka N, Akira M, Kubota K: A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-smallcell lung cancer with brain metastasis. Br J Cancer 74: 614–618, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boogerd, W., van der Sande, J. & van Zandwijk, N. Teniposide Sometimes Effective in Brain Metastases from Non-small Cell Lung Cancer. J Neurooncol 41, 285–289 (1999). https://doi.org/10.1023/A:1006168507111

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006168507111

Navigation